2nd Quarter - Report

VENN STRATEGIES for PACIRA PHARMACEUTICALS INC.

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Improving access to non-opioid approaches to pain management.

LobbyistCovered position, as disclosed
GRAHAM ROY New —
MICHAEL SPIRA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.